Hauptseite > Publikationsdatenbank > Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate > print |
001 | 188458 | ||
005 | 20240619091131.0 | ||
024 | 7 | _ | |a 10.1107/S2053230X14004087 |2 doi |
024 | 7 | _ | |a WOS:000333757800014 |2 WOS |
024 | 7 | _ | |a altmetric:2212845 |2 altmetric |
024 | 7 | _ | |a pmid:24699741 |2 pmid |
037 | _ | _ | |a FZJ-2015-01834 |
082 | _ | _ | |a 530 |
100 | 1 | _ | |a Yokoyama, Takeshi |0 P:(DE-HGF)0 |b 0 |e Corresponding Author |
245 | _ | _ | |a Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate |
260 | _ | _ | |a Oxford [u.a.] |c 2014 |b Blackwell |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1426157276_7587 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a article |2 DRIVER |
520 | _ | _ | |a Nitrogen-containing bisphosphonates (N-BPs), such as risedronate and zoledronate, are currently used as a clinical drug for bone-resorption diseases and are potent inhibitors of farnesyl pyrophosphate synthase (FPPS). X-ray crystallographic analyses of FPPS with N-BPs have revealed that N-BPs bind to FPPS with three magnesium ions and several water molecules. To understand the structural characteristics of N-BPs bound to FPPS, including H atoms and hydration by water, neutron diffraction studies were initiated using BIODIFF at the Heinz Maier-Leibnitz Zentrum (MLZ). FPPS-risedronate complex crystals of approximate dimensions 2.8 × 2.5 × 1.5 mm (~3.5 mm3) were obtained by repeated macro-seeding. Monochromatic neutron diffraction data were collected to 2.4 Å resolution with 98.4% overall completeness. Here, the first successful neutron data collection from FPPS in complex with N-BPs is reported. |
536 | _ | _ | |a 54G - JCNS (POF2-54G24) |0 G:(DE-HGF)POF2-54G24 |c POF2-54G24 |f POF II |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, juser.fz-juelich.de |
650 | 2 | 7 | |a Biology |0 V:(DE-MLZ)SciArea-160 |2 V:(DE-HGF) |x 0 |
650 | 1 | 7 | |a Health and Life |0 V:(DE-MLZ)GC-130-2016 |2 V:(DE-HGF) |x 2 |
650 | 1 | 7 | |a Health and Life |0 V:(DE-MLZ)GC-130-1 |2 V:(DE-HGF) |x 1 |
650 | 1 | 7 | |a Life Science and Health |0 V:(DE-MLZ)GC-130 |2 V:(DE-HGF) |x 0 |
693 | _ | _ | |a Forschungs-Neutronenquelle Heinz Maier-Leibnitz |e BIODIFF: Diffractometer for large unit cells |f NL1 |1 EXP:(DE-MLZ)FRMII-20140101 |0 EXP:(DE-MLZ)BIODIFF-20140101 |5 EXP:(DE-MLZ)BIODIFF-20140101 |6 EXP:(DE-MLZ)NL1-20140101 |x 0 |
700 | 1 | _ | |a Ostermann, Andreas |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Mizuguchi, Mineyuki |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Niimura, Nobuo |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Schrader, Tobias E. |0 P:(DE-Juel1)138266 |b 4 |u fzj |
700 | 1 | _ | |a Tanaka, Ichiro |0 P:(DE-HGF)0 |b 5 |
773 | _ | _ | |a 10.1107/S2053230X14004087 |0 PERI:(DE-600)2175956-X |p 470 |t Acta crystallographica / F |v 70 |y 2014 |x 1744-3091 |
909 | C | O | |o oai:juser.fz-juelich.de:188458 |p VDB:MLZ |p VDB |
910 | 1 | _ | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)138266 |
913 | 2 | _ | |a DE-HGF |b Programmorientierte Förderung |l POF III |1 G:(DE-HGF)POF3 |0 G:(DE-HGF)POF3-600 |2 G:(DE-HGF)POF |v Forschungsbereich Materie |9 G:(DE-HGF)POF3-6G15 |x 0 |
913 | 2 | _ | |a DE-HGF |b Forschungsbereich Materie |l Von Materie zu Materialien und Leben |1 G:(DE-HGF)POF3-620 |0 G:(DE-HGF)POF3-623 |2 G:(DE-HGF)POF3-600 |v Facility topic: Neutrons for Research on Condensed Matter |9 G:(DE-HGF)POF3-6G4 |x 1 |
913 | 1 | _ | |a DE-HGF |b Struktur der Materie |1 G:(DE-HGF)POF2-540 |0 G:(DE-HGF)POF2-54G24 |2 G:(DE-HGF)POF2-500 |v JCNS |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF2 |l Forschung mit Photonen, Neutronen, Ionen |
914 | 1 | _ | |y 2014 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)JCNS-FRM-II-20110218 |k JCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II |l JCNS-FRM-II |x 0 |
920 | 1 | _ | |0 I:(DE-Juel1)JCNS-1-20110106 |k Neutronenstreuung ; JCNS-1 |l Neutronenstreuung |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-Juel1)JCNS-FRM-II-20110218 |
980 | _ | _ | |a I:(DE-Juel1)JCNS-1-20110106 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|